To address these critical issues, we first purified and characterized sarkosyl‐insoluble tau proteopathic seeds extracted from the brains of AD patients (AD‐tau) or extracts obtained from the brains of healthy aged‐matched individuals (CTL‐tau). Here, MAPT is linked to Alzheimer disease.